litlas
ログインアカウント作成

Eitan Amir

2003–2025 年に発表

131
論文数
19,059
被引用数
72
h 指数
120
i10 指数

被引用数

Eitan Amir の年別被引用数1992 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 1 件2004 年: 被引用 2 件2006 年: 被引用 5 件2007 年: 被引用 3 件2008 年: 被引用 7 件2009 年: 被引用 10 件2010 年: 被引用 17 件2011 年: 被引用 41 件2012 年: 被引用 58 件2013 年: 被引用 79 件2014 年: 被引用 97 件2015 年: 被引用 122 件2016 年: 被引用 198 件2017 年: 被引用 203 件2018 年: 被引用 184 件2019 年: 被引用 737 件2020 年: 被引用 964 件2021 年: 被引用 918 件2022 年: 被引用 718 件2023 年: 被引用 501 件2024 年: 被引用 795 件2025 年: 被引用 472 件2026 年: 被引用 8 件1993〜1998 年は被引用が無いため表示していません2001〜2003 年は被引用が無いため表示していません2005 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,836 件、この内訳の 20.1%中国: 引用元論文 1,199 件、この内訳の 13.1%イギリス: 引用元論文 625 件、この内訳の 6.8%イタリア: 引用元論文 571 件、この内訳の 6.3%カナダ: 引用元論文 452 件、この内訳の 4.9%ドイツ: 引用元論文 334 件、この内訳の 3.7%日本: 引用元論文 333 件、この内訳の 3.6%フランス: 引用元論文 289 件、この内訳の 3.2%スペイン: 引用元論文 277 件、この内訳の 3%オランダ: 引用元論文 271 件、この内訳の 3%オーストラリア: 引用元論文 246 件、この内訳の 2.7%ベルギー: 引用元論文 188 件、この内訳の 2.1%
0%20.1%その他 27.5%

機関

分野

  • Medicine68.5%
  • Biochemistry, Genetics and Molecular Biology19.4%
  • Immunology and Microbiology5.2%
  • Computer Science1.3%
  • Economics, Econometrics and Finance1.1%
  • Engineering0.7%
  • その他3.8%

トピック

  • Inflammatory Biomarkers in Disease Prognosis6.2%
  • Cancer Immunotherapy and Biomarkers5%
  • Chemotherapy-induced cardiotoxicity and mitigation3.6%
  • Immune cells in cancer2.5%
  • Breast Cancer Treatment Studies2.4%
  • HER2/EGFR in Cancer Research1.9%
  • その他78.4%

共著者

全論文

検索で開く
  1. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

    著者: Arnoud J. Templeton, Mairéad G. McNamara, Boštjan Šeruga, Francisco Vera-Badillo, Priya Aneja, Alberto Ocaña, Raya Leibowitz‐Amit, Guru Sonpavde, Jennifer J. Knox, Ben Tran, Ian F. Tannock, Eitan Amir - JNCI Journal of the National Cancer Institute 2014 被引用: 3,272

  2. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer

    著者: Fanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, Zhifeng Dong, Julianna Blagih, Matthew G. Annis, Atilla Ömeroğlu, Dongxia Gao, Samuel Leung, Eitan Amir, Mark Clemons, Adriana Aguilar‐Mahecha, Mark Basik, Emma E. Vincent, Julie St‐Pierre, Russell G. Jones, Peter M. Siegel - Cell Metabolism 2015 被引用: 556

  3. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis

    著者: Josée-Lyne Ethier, Danielle Desautels, Arnoud J. Templeton, Prakesh S. Shah, Eitan Amir - Breast Cancer Research 2017 被引用: 693

  4. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

    著者: Evangelos K. Oikonomou, Damianos G. Kokkinidis, Polydoros Ν. Kampaktsis, Eitan Amir, Thomas H. Marwick, Dipti Gupta, Paaladinesh Thavendiranathan - JAMA Cardiology 2019 被引用: 410

  5. Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy

    著者: Paaladinesh Thavendiranathan, Tomoko Negishi, Emily Somerset, Kazuaki Negishi, Martin Pěnička, Julie Lemieux, Svend Aakhus, Sakiko Miyazaki, Mitra Shirazi, Maurizio Galderisi, Thomas H. Marwick, Kazuaki Negishi, Ben Costello, Leah Wright, André La Gerche, Phil Mottram, Liza Thomas, Mitra Shirazi, Martin Pěnička, Tomáš Ondrúš, Stéphanie Seldrum, Krassimira Hristova, Paaladinesh Thavendiranathan, Eitan Amir, Babitha Thampinathan, Julie Lemieux, Marc‐André Côté, Jonathan Deblois, Manish Bansal, Maurizio Galderisi, Ciro Santoro, Koji Kurosawa, Nobuaki Fukuda, Hirotsugu Yamada, Yoshihito Saijo, Sakiko Miyazaki, Masaki Izumo, Tomomi Suzuki, Kazuko Tajiri, Goo‐Yeong Cho, Svend Aakhus, Klaus Murbræch, Richard J. Massey, Wojciech Kosmala, Maciej Siński, Dragoş Vinereanu, Diana Mihalcea, Bogdan A. Popescu, Andreea Călin, Evgeny Shkolnik, José Banchs, Shelby Kutty - Journal of the American College of Cardiology 2020 被引用: 380

  6. Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines

    著者: Paaladinesh Thavendiranathan, Christian Houbois, Thomas H. Marwick, Tiffanie Kei, Sudipta Saha, Kyle Runeckles, Flora Huang, Tamar Shalmon, Kevin E. Thorpe, Rossanna C. Pezo, Anca Prica, Dawn Maze, Husam Abdel‐Qadir, Kim A. Connelly, Joyce Y.T. Chan, Filio Billia, Coleen Power, Kate Hanneman, Bernd J. Wintersperger, Christine Brezden‐Masley, Eitan Amir - European Heart Journal - Cardiovascular Pharmacotherapy 2023 被引用: 106

  7. Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

    著者: Arnoud J. Templeton, Olga Ace, Mairéad G. McNamara, Mustafa Al-Mubarak, Francisco Vera-Badillo, Thomas Hermanns, Boštjan Šeruga, Alberto Ocaña, Ian F. Tannock, Eitan Amir - Cancer Epidemiology Biomarkers & Prevention 2014 被引用: 715

  8. HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer

    著者: T. Barnes, Eitan Amir - British Journal of Cancer 2017 被引用: 442

  9. Integrating artificial intelligence in drug discovery and early drug development: a transformative approach

    著者: Alberto Ocaña, Atanasio Pandiella, Cristian Privat, Iván Bravo, Miguel Luengo-Oroz, Eitan Amir, Balázs Győrffy - Biomarker Research 2025 被引用: 132

  10. Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes

    著者: Alejandro Meraz-Muñoz, Eitan Amir, Pamela Ng, Carmen Ávila-Casado, Claire Ragobar, Christopher T. Chan, S. Joseph Kim, Ron Wald, Abhijat Kitchlu - Journal for ImmunoTherapy of Cancer 2020 被引用: 193

  11. HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates

    著者: Alberto Ocaña, Eitan Amir, Atanasio Pandiella - Breast Cancer Research 2020 被引用: 96

  12. Delivering affordable cancer care in high-income countries

    著者: Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, John Zalcberg, Neal J. Meropol, Eitan Amir, David Khayat, Peter Boyle, Philippe Autier, Ian F. Tannock, Tito Fojo, Jim Siderov, Steve Williamson, Silvia Camporesi, J. Gordon McVie, Arnie Purushotham, Peter Naredi, Alexander Eggermont, Murray F. Brennan, Michael L. Steinberg, Mark De Ridder, Susan A. McCloskey, Dirk Verellen, Terence Roberts, Guy Storme, Rodney J. Hicks, Peter J. Ell, Bradford R. Hirsch, David P. Carbone, Kevin A. Schulman, Paul Catchpole, David Taylor, Jan Geißler, Nancy Brinker, David Meltzer, David Kerr, Matti Aapro - The Lancet Oncology 2011 被引用: 714

  13. Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis

    著者: Anne M. Horgan, Eitan Amir, Thomas Walter, Jennifer J. Knox - Journal of Clinical Oncology 2012 被引用: 720

  14. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer

    著者: Husam Abdel‐Qadir, Peter C. Austin, Douglas S. Lee, Eitan Amir, Jack V. Tu, Paaladinesh Thavendiranathan, Kinwah Fung, George Anderson - JAMA Cardiology 2016 被引用: 311

  15. Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis

    著者: Ana Elisa Lohmann, Sara V. Soldera, Isabel Pimentel, Domen Ribnikar, Marguerite Ennis, Eitan Amir, Pamela J. Goodwin - JNCI Journal of the National Cancer Institute 2021 被引用: 117

  16. Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis

    著者: Eitan Amir, Boštjan Šeruga, Saroj Niraula, Lindsay Carlsson, Alberto Ocaña - JNCI Journal of the National Cancer Institute 2011 被引用: 624

  17. Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study

    著者: Husam Abdel‐Qadir, David Bobrowski, Limei Zhou, Peter C. Austin, Oscar Calvillo‐Argüelles, Eitan Amir, Douglas S. Lee, Paaladinesh Thavendiranathan - Journal of the American Heart Association 2021 被引用: 99

  18. Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis

    著者: Alexandra Desnoyers, Michelle B. Nadler, Vikaash Kumar, Ramy Saleh, Eitan Amir - Cancer Treatment Reviews 2020 被引用: 91

  19. Informative censoring — a neglected cause of bias in oncology trials

    著者: Arnoud J. Templeton, Eitan Amir, Ian F. Tannock - Nature Reviews Clinical Oncology 2020 被引用: 96

  20. Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis

    著者: Husam Abdel‐Qadir, Josée-Lyne Ethier, Douglas S. Lee, Paaladinesh Thavendiranathan, Eitan Amir - Cancer Treatment Reviews 2016 被引用: 254

  21. HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis

    著者: Alberto Ocaña, Francisco Vera-Badillo, Boštjan Šeruga, Arnoud J. Templeton, Atanasio Pandiella, Eitan Amir - JNCI Journal of the National Cancer Institute 2012 被引用: 223

  22. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review

    著者: Andreu Porta‐Sánchez, Cameron Gilbert, Danna Spears, Eitan Amir, Joyce Chan, Kumaraswamy Nanthakumar, Paaladinesh Thavendiranathan - Journal of the American Heart Association 2017 被引用: 218

  23. Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis

    著者: Hadar Goldvaser, T. Barnes, Boštjan Šeruga, David W. Cescon, Alberto Ocaña, Domen Ribnikar, Eitan Amir - JNCI Journal of the National Cancer Institute 2017 被引用: 184

  24. Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C Trial

    著者: Martine Puts, Naser Alqurini, Fay J. Strohschein, Rama Koneru, Ewa Szumacher, Caroline Mariano, Johanne Monette, Tina Hsu, Sarah Brennenstuhl, Bianca McLean, Aria Wills, Arielle Berger, Eitan Amir, Lindy Romanovsky, Anson Li, Rajin Mehta, Monika K. Krzyzanowska, Christine Elser, Raymond Jang, Anca Prica, D. Wan-Chow-Wah, Eric Pitters, Urban Emmenegger, Ines B. Menjak, Simon Bergman, Manon Lemonde, Henriette Breunis, François Béland, Shabbir M.H. Alibhai - Journal of Clinical Oncology 2022 被引用: 80